All our news

Card image cap
GDPR - Our privacy policy
05/25/2018

SSCB Swiss Stem Cells Biotech takes care of your privacy. This is why we publish our privacy policy on http://privacy.stembiotech.ch. For [...]

Card image cap
Stamen, succeeded in the first transplant to the eye
07/02/2017

Three almost completely blind people will recover, at least in part, the sight thanks to the first ”liquid” transplant in the field of ophthalmology in Italy.The intervention - pionee [...]

Card image cap
Dr. Joanne Kurtzberg: "The potential for cord blood to treat very serious illness now only begins to be understood"
05/30/2017

”I believe that cord blood has a long development path ahead of it, what once was considered simply one of the many biological waste to be thrown out after birth is instead a precious source of s [...]

Card image cap
Bilateral hands transplantation. The first anti-rejection therapy with stem cells.
03/31/2017

San Gerardo Hospital in Monza has been involved in bilateral transplants and has been a success of world proportions. This is the first case in the world of anti-rejection therapy with mesenchymal [...]

Card image cap
Calendar 2017: Free training sessions on cord stem cells
03/29/2017

Umbilical cord blood is a natural and precious source of stem cells that are already involved in the treatment of pathologies such as leukemia, lymphoma, and metabolic disorders.In order to [...]

Card image cap
Myasthenia Gravis treated with autologous haematopoietic stem cell transplantation
03/29/2017

JAMA Neurology has recently published the results of a clinical trial performed on 7 cases of severe [...]

Card image cap
The FACT-NETCORD accreditation has been renewed. SSCB is confirmed a top quality cord bank
03/29/2017

By demonstrating compliance with the NETCORD-FACT International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release, SSCB has earned the renewal of NETCORD-FACT [...]